The Etiology of Growth Hormone Deficiency in the Human Adult

  • E. R. Christ
  • P. V. Carroll
  • P. H. Sönksen
Part of the Endocrine Updates book series (ENDO, volume 4)


Although growth hormone (GH) deficiency in human adults is now recognised as a specific clinical syndrome (1–2) and the effects of GH replacement have been extensively studied (1–2), little systematic information exists regarding the etiology of GH-deficiency acquired in adulthood. This may be explained by the fact that until recently most physicians considered GH to have little function in adulthood and it is only in the last decade that this topic has received widespread attention.


Growth Hormone Pituitary Tumour Growth Hormone Deficiency Growth Hormone Secretion Proliferative Diabetic Retinopathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    De Boer H, Blok GJ, van der Veen VA. Clinical aspects of growth hormone deficiency in adults. Endocrine Reviews 1995;16:63–86.PubMedCrossRefGoogle Scholar
  2. 2.
    Christ ER, Carroll PV, Russell-Jones DL, Sönksen PH. The consequences of growth hormone deficiency in adulthood, and the effects of growth hormone replacement. Schw Med. Wochenschrift 1997;127:1440–1449Google Scholar
  3. 3.
    Frohman LA, Jansson JO. GHRH. Endocrine Reviews 1986;7:223–253PubMedCrossRefGoogle Scholar
  4. 4.
    Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews. 1995;16:3–34.PubMedGoogle Scholar
  5. 5.
    Kiess W, Kessler U, Schmitt S, Funk B. Growth hormone and insulin-like growth factor-I. In: Growth hormone and IGF-I in human and experimental diabetes.Published by John Wiley and Sons 1993.Google Scholar
  6. 6.
    Kelly PA, Djiane J, Postel-Vinay M-C, Edery M. The PRL/GH receptor family. Endocrine Reviews 1991;12:235–251.PubMedCrossRefGoogle Scholar
  7. 7.
    Godowski PJ, Leung DW, Meacham LR et al. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proceedings of the National Academy of Sciences of the USA. 1989;86:8083–8087.PubMedCrossRefGoogle Scholar
  8. 8.
    Laron Z, Anin S, Klipper-Aurbach Y, Klinger B. Effects of insulin-like growth factor on linear growth, head circumference and body fat in patients with Laron-type dwarfism. Lancet 1992;339:1258–1261.PubMedCrossRefGoogle Scholar
  9. 9.
    Salomon F, Cuneo RD, Hesp R, Sönksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine 1989;321:1797–1803.PubMedCrossRefGoogle Scholar
  10. 10.
    Jorgensen JOL, Pedersen SA, Thuesen L et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989; i: 1221–1225.CrossRefGoogle Scholar
  11. 11.
    Rosen T, Bengtsson B-Å. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;336:285–288PubMedCrossRefGoogle Scholar
  12. 12.
    Bates AS, Van’t Hoff W, Jones PJ, Clayton RN. The effect of hyopituitarism on life expectancy. Journal of Clinical Endocrinology & Metabolism 1996;81:1169–1172CrossRefGoogle Scholar
  13. 13.
    Bulow B, Hagmar, Mikozy Z, Nordstroem CH, Erfurth EM. Increased cerebrovascular mortality in patients with hypopituitarism. Clinical Endocrinology 1997;46:75–81.PubMedCrossRefGoogle Scholar
  14. 14.
    Attanasio AF, Lamberts SWJ, Matranga AMC, Birkett MA, Bates PC, Valk NK, Hilsted J, Bengtsson BA, Strasburger CJ. Adult growth hormonedeficient patients demonstrate heterogenity between childhood onset and adult onset before and during human GH treatment. Journal of Clinical Endocrinology & Metabolism 1997;82:82–88.CrossRefGoogle Scholar
  15. 15.
    Toogood AA, Beardwell CG, Shalet SM. The severity of GH-deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clinical Endocrinology.1994;41:511–516.PubMedCrossRefGoogle Scholar
  16. 16.
    Cacciari E, Tassoni P, Parisi G et al. Pittfalls in diagnosing impaired GH secretion: Retesting after replacement therapy of 63 patients defined as GH deficient. Journal of Clinical Endocrinology and Metabolism. 1992;74:1284–1289.PubMedCrossRefGoogle Scholar
  17. 17.
    Clayton PE, Price DA, Shalet SM. Growth hormone state after completion of treatment with growth hormone. Archives od Diseases in Childhood. 1987;62:222–226.CrossRefGoogle Scholar
  18. 18.
    Nicolson A, Toogood AA, Rahim A, Shalet SM. The prevalence of severe GH-deficiency in adults who received GH replacement in childhood. Clinical Endocrinology. 1996;44:311–316.PubMedCrossRefGoogle Scholar
  19. 19.
    Weissberger AJ, Ho KK. Activation of the somatotrophic axis by testosterone an adult males: evidence for the role of aromatization. Journal of Clinical Endocrinology and Metabolism. 1993;76:1407–1412PubMedCrossRefGoogle Scholar
  20. 20.
    Bowes SB, Umpleby M, Cummings MH, Jackson NC et al. The effect of recombinant human GH on glucose and leucine metabolism in Cushing’s syndrome. Journal of Clinical Endocrinology and Metabolism. 1996;82:243–246.CrossRefGoogle Scholar
  21. 21.
    Littley MD, Shalet SM, Beardwell CG et al. Hypopituitarism following external radiotherapy for pituitary tumours in adults. Quarterly Journal of Medicine. 1989;70:145–160.PubMedGoogle Scholar
  22. 22.
    Tan BC, Kunaratnam N. Hypopituitary dwarfism following radiotherapy for nasopharyngeal carcinoma. Clinical Radiology. 1966;17:302–304PubMedCrossRefGoogle Scholar
  23. 23.
    Sheline GE, Wara WM, Smith V. Therapeutic irradiation and brain injury. International Journal of Radiation Oncology Biology Physics. 1980;6:1215–122819..CrossRefGoogle Scholar
  24. 24.
    Ahmed SR, Shalet SM. Hypothalamic growth hormone releasing factor deficiency following cranial irradiation. Clinical Endocrinology. 1984;21:483–488.PubMedCrossRefGoogle Scholar
  25. 25.
    Shalet SM. Irradiation induced growth failure. Clinics in Endocrinology and Metabolism. 1986;15:591–606.PubMedCrossRefGoogle Scholar
  26. 26.
    Litüey MD, Shalet SM, Beardwell CG. Radiation and hypothalamic-pituitary function. Baillieres Clinical Endocrinology and Metabolism. 1990;4:147–175.CrossRefGoogle Scholar
  27. 27.
    Lam KSL, Tse VKC, Wang C et al. Early effects of cranial irradiation on hypothalamic-pituitary function. Journal of Clinical Endocrinology and Metabolism. 1987;64:418–424.PubMedCrossRefGoogle Scholar
  28. 28.
    Littley MD, Shalet SM, Beardwell CG, Robinson EL, Sutton ML. Radiation induced hypopituitarism is dose-dependent. Clinical Endocrinology. 1989;31:363–373.PubMedCrossRefGoogle Scholar
  29. 29.
    Sharp PS, Fallon TJ, Brazier OJ et al. Long term follow-up of patients who underwent Yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy. Diabetologia. 1987;30:199–207.PubMedCrossRefGoogle Scholar
  30. 30.
    Cogan JD, Phillips JA, Sakati, N, Frisch H, Schober E, Milner RDG. Heteerogenous growth hormone (GH) gene mutations in familial GH deficiency. Journal of Clinical Endocrinology and Metabolism. 1993;76:1224–1228.PubMedCrossRefGoogle Scholar
  31. 31.
    Vimpani GV, Vimpani AF, Lidgard GP, Cameron EHD, Farquhar JW. Prevalence of severe growth hormone deficiency. British Medical Journal. 1977;2:427–430.PubMedCrossRefGoogle Scholar
  32. 32.
    Perez-Jurado LA, Argente J. Molecular basis of familial growth hormone deficiency. Hormone Research. 1994;42:189–197.PubMedCrossRefGoogle Scholar
  33. 33.
    Cohen LE, Wondisford FE, Salvatoni A, Maghnie M, Brucker-Davis F, Weintraub BD, Radovick S. Journal of Clinical Endocrinology and Metabolism. 1995;80:679–684.PubMedCrossRefGoogle Scholar
  34. 34.
    Ozbey N, Inane S, Aral F. et al. Clinical and laboratory evaluation of 40 patients with Sheehan’s syndrome. Israel Journal of Medical Sciences. 1994;30:826–829.PubMedGoogle Scholar
  35. 35.
    Pfadenhauer K, Roesler A, Herzog P, Grumme T. Adenomatous hypophyseal apoplexy. Clinical, diagnostic and therapeutic aspects of a frequently misdiagnosed emergency state. Nervenarzt. 1995;66:288–292.PubMedGoogle Scholar
  36. 36.
    Frenandez-Real JM, Fernandez-castaner M, Villabona C et al. Giant intrasellar aneurysm presenting with panhypopituitarism and subarachnoidal hemorrhagexase report and literature review. Clinical Investigator. 1994;72:302–306.Google Scholar
  37. 37.
    Suh DC, Park JS, Park SK, Lee HK, Chang KH. Pituitary hemorrhage as a complication of hantaviral disease. American Journal of Neuroradiology. 1995;16:175–178.PubMedGoogle Scholar
  38. 38.
    Ruiz-Hernandez G, Chesa-Jimenez J, San Martin Ciges E. et al. Panhypopituitarism as a consequence of metastase of breast cancer in sella turcica. Nuklearmedizin. 1996;35:143–145.PubMedGoogle Scholar
  39. 39.
    Ko JC, Yang PC, Huang TS, Yeh KH, Kuo SH, Luh KT. Panhypopituitarism caused by solitary parasellar metastasis from lung cancer. Chest. 1994;105:951–953.PubMedCrossRefGoogle Scholar
  40. 40.
    Lam KS, Sham MM, Tarn SC, Ng. MM, Ma HT. Hypopituitarism after tuberculous menigitis in childhood. Annales of Internal Medicine. 1993;118:701–706.Google Scholar
  41. 41.
    Patel MC, Guneratne N, Haq N, West TE, Weetham AP, Clayton RN. Paripartum hypopituitarism and lymphocytic hypophysitis. Quarterly Journal of Medicine. 1995;88:571–580.Google Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • E. R. Christ
    • 1
  • P. V. Carroll
    • 1
  • P. H. Sönksen
    • 1
  1. 1.Division of MedicineSt. Thomas’ HospitalLondonUK

Personalised recommendations